191 related articles for article (PubMed ID: 23337501)
1. Applications for nitric oxide in halting proliferation of tumor cells.
Reynolds MM; Witzeling SD; Damodaran VB; Medeiros TN; Knodle RD; Edwards MA; Lookian PP; Brown MA
Biochem Biophys Res Commun; 2013 Feb; 431(4):647-51. PubMed ID: 23337501
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide donors: novel cancer therapeutics (review).
Huerta S; Chilka S; Bonavida B
Int J Oncol; 2008 Nov; 33(5):909-27. PubMed ID: 18949354
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase G activity prevents pathological-level nitric oxide-induced apoptosis and promotes DNA synthesis/cell proliferation in vascular smooth muscle cells.
Wong JC; Fiscus RR
Cardiovasc Pathol; 2010; 19(6):e221-31. PubMed ID: 20060325
[TBL] [Abstract][Full Text] [Related]
4. Role of redox signaling and poly (adenosine diphosphate-ribose) polymerase activation in vascular smooth muscle cell growth inhibition by nitric oxide and peroxynitrite.
Huang J; Lin SC; Nadershahi A; Watts SW; Sarkar R
J Vasc Surg; 2008 Mar; 47(3):599-607. PubMed ID: 18295111
[TBL] [Abstract][Full Text] [Related]
5. Sensitizing activities of nitric oxide donors for cancer resistance to anticancer therapeutic drugs.
Bonavida B
Biochem Pharmacol; 2020 Jun; 176():113913. PubMed ID: 32173364
[TBL] [Abstract][Full Text] [Related]
6. The NO TRAIL to YES TRAIL in cancer therapy (review).
Lee JY; Huerta-Yepez S; Vega M; Baritaki S; Spandidos DA; Bonavida B
Int J Oncol; 2007 Oct; 31(4):685-91. PubMed ID: 17786298
[TBL] [Abstract][Full Text] [Related]
7. Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastases.
Bonavida B; Baritaki S; Huerta-Yepez S; Vega MI; Chatterjee D; Yeung K
Nitric Oxide; 2008 Sep; 19(2):152-7. PubMed ID: 18477483
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide: a key regulator of myeloid inflammatory cell apoptosis.
Taylor EL; Megson IL; Haslett C; Rossi AG
Cell Death Differ; 2003 Apr; 10(4):418-30. PubMed ID: 12719719
[TBL] [Abstract][Full Text] [Related]
9. Small molecules for great solutions: Can nitric oxide-releasing nanomaterials overcome drug resistance in chemotherapy?
Pieretti JC; Pelegrino MT; Nascimento MHM; Tortella GR; Rubilar O; Seabra AB
Biochem Pharmacol; 2020 Jun; 176():113740. PubMed ID: 31786262
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of nitric oxide donors impact on cisplatin resistance in various ovarian cancer cell lines.
Kielbik M; Szulc-Kielbik I; Nowak M; Sulowska Z; Klink M
Toxicol In Vitro; 2016 Oct; 36():26-37. PubMed ID: 27427240
[TBL] [Abstract][Full Text] [Related]
11. Identifying urotropine derivatives as co-donors of formaldehyde and nitric oxide for improving antitumor therapy.
Zhang Y; Feng S; Meng X; Luo J; Xu Y; Ning X
Chem Commun (Camb); 2021 Aug; 57(61):7581-7584. PubMed ID: 34250986
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide donors prevent while the nitric oxide synthase inhibitor L-NAME increases arachidonic acid plus CYP2E1-dependent toxicity.
Wu D; Cederbaum A
Toxicol Appl Pharmacol; 2006 Oct; 216(2):282-92. PubMed ID: 16938321
[TBL] [Abstract][Full Text] [Related]
13. NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin.
Konturek PC; Kania J; Burnat G; Hahn EG
J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():15-24. PubMed ID: 17244951
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of nitric oxide in cancer.
Bonavida B; Khineche S; Huerta-Yepez S; Garbán H
Drug Resist Updat; 2006 Jun; 9(3):157-73. PubMed ID: 16822706
[TBL] [Abstract][Full Text] [Related]
15. Overexpressed beta-catenin blocks nitric oxide-induced apoptosis in colonic cancer cells.
Wang H; MacNaughton WK
Cancer Res; 2005 Oct; 65(19):8604-7. PubMed ID: 16204024
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide affects immune cells bioenergetics: long-term effects of nitric-oxide derivatives on leukaemic Jurkat cell metabolism.
Hammami I; Bertrand M; Chen J; Bronte V; De Crescenzo G; Jolicoeur M
Immunobiology; 2012 Aug; 217(8):808-15. PubMed ID: 22656888
[TBL] [Abstract][Full Text] [Related]
17. Novel nitric oxide generating compound glycidyl nitrate enhances the therapeutic efficacy of chemotherapy and radiotherapy.
Ning S; Bednarski M; Oronsky B; Scicinski J; Knox SJ
Biochem Biophys Res Commun; 2014 May; 447(3):537-42. PubMed ID: 24735538
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of the safe margin, antithrombotic and antiproliferative actions for the treatment of restenosis: Nitric oxide donor and polymers.
Sorragi Cde L; Shishido SM; Lemos ME; Marcondes S; Antunes E; Krieger MH
Cell Biochem Funct; 2011 Apr; 29(3):207-14. PubMed ID: 21374644
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide: cancer target or anticancer agent?
Mocellin S
Curr Cancer Drug Targets; 2009 Mar; 9(2):214-36. PubMed ID: 19275761
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide-releasing drugs.
Napoli C; Ignarro LJ
Annu Rev Pharmacol Toxicol; 2003; 43():97-123. PubMed ID: 12540742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
